Global News and Digital Insights
for the Healthcare Industry

Category: Pharma

Pfizer to offer refund for its new drug Panzyga

After mulling over the idea for several years, the pharma giant, Pfizer, is set to protect its patients and promote its new drug ‘Panzyga’, for the rare disorder, chronic inflammatory demyelinating polyneuropathy (CIPD), through the warranty programme.

Pfizer to offer refund for its new drug Panzyga

After mulling over the idea for several years, the pharma giant, Pfizer, is set to protect its patients and promote its new drug ‘Panzyga’, for the rare disorder, chronic inflammatory demyelinating polyneuropathy (CIPD), through the warranty programme.